Email Alert | RSS    帮助

中国防痨杂志 ›› 2022, Vol. 44 ›› Issue (12): 1279-1287.doi: 10.19982/j.issn.1000-6621.20220284

• 论著 • 上一篇    下一篇

2014—2019年广州市耐药肺结核高危人群耐药情况及影响因素分析

沈鸿程1, 杜雨华1, 张丹妮2, 吴桂锋1, 雷宇1, 肖新才1, 刘健雄1()   

  1. 1广州市胸科医院结核病控制管理科,广州 510095
    2广州医科大学公共卫生学院,广州 511436
  • 收稿日期:2022-07-28 出版日期:2022-12-10 发布日期:2022-12-02
  • 通信作者: 刘健雄 E-mail:Ljxer64@qq.com
  • 基金资助:
    广州市科技计划项目(202201010095);广州市卫生健康科技重大项目(2020A031003)

Analysis of drug resistance situation and influencing factors among high-risk group of drug-resistant tuberculosis in Guangzhou, 2014—2019

Shen Hongcheng1, Du Yuhua1, Zhang Danni2, Wu Guifeng1, Lei Yu1, Xiao Xincai1, Liu Jianxiong1()   

  1. 1Department of Tuberculosis Control and Prevention, Guangzhou Chest Hospital, Guangzhou 510095, China
    2School of Public Health, Guangzhou Medical University, Guangzhou 511436, China
  • Received:2022-07-28 Online:2022-12-10 Published:2022-12-02
  • Contact: Liu Jianxiong E-mail:Ljxer64@qq.com
  • Supported by:
    Guangzhou Science and Technology Planning Project(202201010095);Guangzhou Health Science and Technology Major Project(2020A031003)

摘要:

目的: 分析广州市耐药肺结核高危人群耐药情况及特征,以及耐药发生的影响因素。 方法: 从“中国疾病预防控制信息系统”的子系统“结核病管理信息系统”中搜集广州市2014年1月1日至2019年12月31日期间登记的耐药肺结核高危人群资料,包括社会人口学特征、耐药筛查结果等资料,最终纳入2155例研究对象的相关信息。分析研究对象对5种抗结核药品[异烟肼(isoniazid,INH)、利福平(rifampicin,RFP)、乙胺丁醇(ethambutol,EMB)、氧氟沙星(ofloxacin,Ofx)、卡那霉素(kanamycin,Km)]的耐药情况、耐药顺位、耐药谱,以及影响耐药发生的因素。 结果: 2155例研究对象中有768例耐药,总耐药率为35.64%,单耐药率、耐多药率、广泛耐药率分别为10.39%(224/2155)、24.36%(525/2155)、0.88%(19/2155)。研究对象对5种抗结核药品的耐药顺位由高到低依次为INH(31.97%,689/2155)、RFP(29.05%,626/2155)、EMB(10.72%,231/2155)、Ofx(7.75%,167/2155)、Km(2.55%,55/2155)。耐1种药品至耐5种药品的比例分别为24.22%(186/768)、39.97%(307/768)、24.87%(191/768)、9.38%(72/768)和1.56%(12/768)。耐1种药品者中,以耐INH最多,占15.23%(117/768);耐2种药品者中,以耐INH+RFP最多,占35.94%(276/768);耐3种药品者中,以耐INH+RFP+EMB最多,占16.80%(129/768);耐4种药品者中,以耐INH+RFP+EMB+Ofx最多,占6.51%(50/768)。多因素logistic回归分析结果显示,≥65岁组患者耐药发生风险是<25岁组的37.9%(OR=0.379,95%CI:0.226~0.634);职业分类中,商业服务,教师、医务人员及干部职员,农民,以及其他者耐药发生风险分别是离退休人员的2.419倍(95%CI:1.429~4.096)、2.541倍(95%CI:1.325~4.873)、1.479倍(95%CI:1.028~2.127)、6.452倍(95%CI:4.624~9.003);患者分类中,初治失败、复治失败/慢性患者、复发、其他者耐药发生风险分别是初治2、3个月末痰涂片阳性者的9.443倍(95%CI:6.009~14.621)、7.504倍(95%CI:4.634~12.151)、2.567倍(95%CI:1.968~3.348)和3.091倍(1.969~4.854)。 结论: 近年来广州市耐药肺结核高危人群中超过1/3出现耐药,耐药形势不容忽视。耐药肺结核高危人群中要重点关注中青年,关注商业服务、教师、医生、企事业单位职员、农民等从业者,关注初治失败、复治失败/慢性患者、复发等人群。

关键词: 结核,肺, 抗药性,细菌, 因素分析,统计学, 危险因素

Abstract:

Objective: To analyze the status and characteristics of drug resistance and influencing factors among high-risk group of drug resistant tuberculosis in Guangzhou. Methods: Information of 2155 high-risk group of drug-resistant tuberculosis in Guangzhou from January 1, 2014 to December 31, 2019 was collected from “Tuberculosis Management Information System of China Information System for Disease Control and Prevention”, including sociodemographic characteristics, drug resistance screening results and so on, relevant information of 2155 subjects was finally included. Drug resistance status, sequence, spectrum and influencing factors of five anti-tuberculosis drugs including isoniazid (INH), rifampicin (RFP), ethambutol (EMB), ofloxacin (Ofx) and kanamycin (Km) were analyzed. Results: Among 2155 subjects, 768 were drug resistant cases, with the total drug resistance rate of 35.64%. The rates of single drug resistance, multi-drug resistance, and extensively drug resistance were 10.39% (224/2155), 24.36% (525/2155), and 0.88% (19/2155), respectively. The drug resistance rates of INH, RFP, EMB, Ofx, Km were 31.97% (689/2155), 29.05% (626/2155), 10.72% (231/2155), 7.75% (167/2155), 2.55% (55/2155), respectively. The percentages of drug resistance including 1 to 5 anti-tuberculosis drugs were 24.22% (186/768), 39.97% (307/768), 24.87% (191/768), 9.38% (72/768) and 1.56% (12/768), respectively. Among the single drug resistance subjects, INH was the most common, accounting for 15.23% (117/768); among those who resistant to 2 anti-tuberculosis drugs, INH+RFP was the most common, accounting for 35.94% (276/768); among those who resistant to 3 anti-tuberculosis drugs, INH+RFP+EMB resistance was the most common, accounting for 16.80% (129/768); among those who resistant to 4 anti-tuberculosis drugs, INH+RFP+EMB+Ofx was the most common, accounting for 6.51% (50/768). Multivariate logistic regression analysis showed that the risk of drug resistance in patients ≥65 years old was 37.9% of the patients <25 years old (OR=0.379, 95%CI: 0.226-0.634); as to the occupational classification, the risk of drug resistance in business service, teachers, medical staff and cadres, farmers, and others was 2.419 times (95%CI: 1.429-4.096), 2.541 times (95%CI: 1.325-4.873), 1.479 times (95%CI: 1.028-2.127), and 6.452 times (95%CI: 4.624-9.003) that of retirees, respectively; as to the classification of patients, the risk of drug resistance of initial treatment failure, retreatment failure/chronic patients, relapse and others was 9.443 times (95%CI: 6.009-14.621), 7.504 times (95%CI: 4.634-12.151), 2.567 times (95%CI: 1.968-3.348) and 3.091 times (95%CI: 1.969-4.854) that of sputum smear positive patients at the end of 2 and 3 months after initial treatment, respectively. Conclusion: In recent years, more than 1/3 of the high-risk group of drug resistant tuberculosis in Guangzhou has developed drug resistance, and the situation of drug resistance cannot be ignored. Among the high-risk group of drug resistant tuberculosis, we should focus on young and middle-aged people, business services, teachers, doctors, employees of enterprises and institutions, farmers and other practitioners, as well as people who have failed initial treatment, failed retreatment/chronic patients, and relapsed.

Key words: Tuberculosis, pulmonary, Drug resistance, bacterial, Factor analysis, statistical, Risk factors

中图分类号: